# HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease

> **NCT01100099** · PHASE2,PHASE3 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 100 (actual)

## Conditions studied

- Celiac Disease
- Gluten

## Interventions

- **DIETARY_SUPPLEMENT:** Gluten challenge.

## Key facts

- **NCT ID:** NCT01100099
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2009-12
- **Final completion:** 2012-09
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2012-09-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01100099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01100099, "HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01100099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*